Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Close this folder7. The editorial process
View the document7.1 Outline of the editorial process
Open this folder and view contents7.2 Editing a drug bulletin
Open this folder and view contents7.3 Writing bulletin articles
Open this folder and view contents7.4 Reviewing the article
View the document7.5. Rewriting the article
View the document7.6 Final checks
Open this folder and view contents7.7 Follow-up after publication
View the document7.8 References
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

7.5. Rewriting the article

Management of reviewers' comments is not always easy and the skills of experienced editors are helpful. These are the main steps used by ISDB bulletins in rewriting articles:

• before looking at the comments some bulletins suggest that the author or the editor rereads the article and makes his or her own comments on it;

• first consider comments from reviewers that are easy to integrate: style, wording, length of sentences, technical points with simple and clear references, etc.;

• deal with technically complex and/or controversial comments at the end, in some cases through personal contacts with the reviewers;

• in some cases, you may want to re-circulate very controversial articles to a smaller group for final consensus. Some bulletins, such as the Drug and Therapeutics Bulletin (UK), do this systematically.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014